NUNZIUM

News That Matters

15/09/2022 ---- 16/09/2022

The Shanghai Cooperation Organization (SCO) was set up in 2001 as a political, economic and security organisation to rival Western institutions. Member countries are China, India, Pakistan, Russia, Kazakhstan, Kyrgyzstan, Tajikistan and Uzbekistan. This year, among others, also leaders of Belarus, Iran, and Turkey participated to the meeting - which took place in Samarkand, Uzbekistan. President of China Xi Jinping, president of Russia Vladimir Putin, president of India Narendra Modi, and president of Turkey Recep Tayyip Erdogan were present. This meeting marks another milestone towards a more intense financial, economic, and political cooperation between nations in Central Asia. Russia has closed deals with Turkey, India, China, and Mongolia to increase significantly energy export towards Asia. President Xi, during his keynote speech, outlined several priorities going forward for the SCO state members, including enhancing solidarity and cooperation, maintaining strategic independence and safeguarding regional stability, pursuing inclusiveness and shared benefits in promoting development cooperation. On the situation in Ukraine, with counteroffensives underway against Russia, some contrasting views were shared: while Putin confirmed Russia’s will to endure until reaching “liberation of Donbas”, no direct support was offered by any country - China included - and India’s president Modi further expressed concern. In his words: “I know today’s era is not of war. We discussed this issue with you on phone several times, that democracy, diplomacy and dialogue touch the entire world […] Today the biggest worry before the world, especially developing countries, is food security, fuel security, fertilisers. We must find ways to these problems and you will also have to consider” he said to Putin. The meeting concluded with leaders signing a declaration containing statements of shared effort on safeguarding global food security and energy security, addressing climate change, and maintaining a secure, stable and diversified supply chain.

READ MORE

Whereas women can choose between many methods of contraception, so far the choice for men is reduced to condom or vasectomy - which implies permanent infertility. To overcome this barrier, scientist at the University of Minnesota developed a male pill soon to be tested in a human clinical trial. So far, the data showed that the pill is 99 per cent effective in mice without causing adverse effects. Another option is coming from the University of Edinburgh, where a team developed a shoulder gel releasing the hormone progestin, able to block testosterone production and therefore reducing sperm production. The gel is being evaluated in Phase 2 clinical trials in US. Getting these new options to the market will take between 5 and 10 years mainly because the trials must not only demonstrate the efficacy of the product in preventing the pregnancies, but also the reversibility of the effect - meaning that the couples must manage to conceive once they decide to stop the treatment. With female rights debate on the rise, especially after the decision of the US Supreme Court about the right of abortion (June 24) and the anti-abortion laws passed in Hungary (September 15), male contraceptives may slowly become important to political and societal debates.

READ MORE